Collegium Pharmaceutical Inc (COLL)
37.53
+0.02
(+0.05%)
USD |
NASDAQ |
May 03, 16:00
37.53
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Market Cap: 1.199B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 1.199B |
| May 01, 2024 | 1.207B |
| April 30, 2024 | 1.180B |
| April 29, 2024 | 1.173B |
| April 26, 2024 | 1.164B |
| April 25, 2024 | 1.145B |
| April 24, 2024 | 1.134B |
| April 23, 2024 | 1.149B |
| April 22, 2024 | 1.110B |
| April 19, 2024 | 1.113B |
| April 18, 2024 | 1.111B |
| April 17, 2024 | 1.133B |
| April 16, 2024 | 1.131B |
| April 15, 2024 | 1.123B |
| April 12, 2024 | 1.141B |
| April 11, 2024 | 1.163B |
| April 10, 2024 | 1.214B |
| April 09, 2024 | 1.240B |
| April 08, 2024 | 1.260B |
| April 05, 2024 | 1.278B |
| April 04, 2024 | 1.256B |
| April 03, 2024 | 1.261B |
| April 02, 2024 | 1.227B |
| April 01, 2024 | 1.243B |
| March 28, 2024 | 1.241B |
| Date | Value |
|---|---|
| March 27, 2024 | 1.307B |
| March 26, 2024 | 1.276B |
| March 25, 2024 | 1.284B |
| March 22, 2024 | 1.269B |
| March 21, 2024 | 1.268B |
| March 20, 2024 | 1.240B |
| March 19, 2024 | 1.213B |
| March 18, 2024 | 1.258B |
| March 15, 2024 | 1.249B |
| March 14, 2024 | 1.215B |
| March 13, 2024 | 1.224B |
| March 12, 2024 | 1.195B |
| March 11, 2024 | 1.198B |
| March 08, 2024 | 1.202B |
| March 07, 2024 | 1.189B |
| March 06, 2024 | 1.172B |
| March 05, 2024 | 1.160B |
| March 04, 2024 | 1.183B |
| March 01, 2024 | 1.187B |
| February 29, 2024 | 1.173B |
| February 28, 2024 | 1.169B |
| February 27, 2024 | 1.176B |
| February 26, 2024 | 1.168B |
| February 23, 2024 | 1.162B |
| February 22, 2024 | 1.049B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
339.51M
Minimum
Jul 22 2019
1.307B
Maximum
Mar 27 2024
714.01M
Average
706.31M
Median
Sep 15 2021
Market Cap Benchmarks
| Immunogen Inc (DELISTED) | -- |
| Supernus Pharmaceuticals Inc | 1.688B |
| AnaptysBio Inc | 711.10M |
| Recursion Pharmaceuticals Inc | 2.077B |
| Nuvalent Inc | 4.507B |
Market Cap Related Metrics
| PE Ratio | 31.54 |
| PS Ratio | 2.995 |
| Price to Book Value | 6.137 |
| Price to Free Cash Flow | 6.189 |
| Price | 37.53 |
| Earnings Yield | 3.17% |
| Operating PE Ratio | 10.17 |
| Normalized PE Ratio | 20.07 |